HomeYMAB • NASDAQ
Y-mAbs Therapeutics Inc
add
$4.91
0.61%
Pre-market:(26.68%)-1.31
$3.60
Closed: Mar 13, 6:28:15 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 26.50M | 13.41% |
Operating expense | 23.02M | -6.15% |
Net income | -6.79M | -587.25% |
Net profit margin | -25.63 | -505.91% |
Earnings per share | -0.15 | -650.00% |
EBITDA | -4.26M | -40.26% |
Effective tax rate | 9.97% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.23M | -14.50% |
Total assets | 119.90M | -6.23% |
Total liabilities | 27.90M | 3.78% |
Total equity | 92.00M | — |
Shares outstanding | 45.22M | — |
Price to book | 2.41 | — |
Return on assets | -9.06% | — |
Return on capital | -11.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.79M | -587.25% |
Cash from operations | -1.87M | 76.73% |
Cash from investing | — | — |
Cash from financing | 986.00K | 886.00% |
Net change in cash | -888.00K | 88.81% |
Free cash flow | -1.33M | 70.93% |
Previous close
$4.94
Day range
$4.79 - $5.03
Year range
$4.26 - $17.78
Market cap
219.91M USD
Avg Volume
486.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
104
